Literature DB >> 15006707

RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients.

W Vollmar1, J Gloger, E Berger, G Kortenbruck, R Köhling, E-J Speckmann, U Musshoff.   

Abstract

Editing and alternative splicing of mRNA are posttranscriptional steps probably involved in pathophysiological aspects of epilepsy. The present study analyses the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluR2 with respect to the expression of (i) editing at the R/G site and (ii) flip-flop cassettes. Nervous tissue from patients with temporal lobe epilepsy was analysed by RT-PCR followed by restriction enzyme assays. Human autoptic tissue served as control. R/G editing status: the relative amount of edited RNA was significantly increased in the hippocampal tissue, whereas no changes were found in neocortical tissues. Flip-flop expression: no significant alterations were found in relative abundance of spliced variants containing the flip exon. The increased editing at the R/G site in the hippocampal tissue of epilepsy patients may enhance responses to glutamate, resulting in a synapse operating at an increased gain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006707     DOI: 10.1016/j.nbd.2003.11.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  23 in total

Review 1.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 2.  The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience.

Authors:  Bernhard J Steinhoff
Journal:  Ther Adv Neurol Disord       Date:  2015-05       Impact factor: 6.570

Review 3.  Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurobiol Dis       Date:  2010-02-24       Impact factor: 5.996

4.  Ionotropic glutamate receptor mRNA editing in the prefrontal cortex: no alterations in schizophrenia or bipolar disorder.

Authors:  Rebecca Lyddon; Scott Navarrett; Stella Dracheva
Journal:  J Psychiatry Neurosci       Date:  2012-07       Impact factor: 6.186

Review 5.  The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Claire L Palmer; Lucy Cotton; Jeremy M Henley
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 6.  A mark of disease: how mRNA modifications shape genetic and acquired pathologies.

Authors:  Eliana Destefanis; Gülben Avşar; Paula Groza; Antonia Romitelli; Serena Torrini; Pınar Pir; Silvestro G Conticello; Francesca Aguilo; Erik Dassi
Journal:  RNA       Date:  2020-12-29       Impact factor: 4.942

7.  Editing of AMPA and serotonin 2C receptors in individual central neurons, controlling wakefulness.

Authors:  Olga A Sergeeva; Bettina T Amberger; Helmut L Haas
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 4.231

8.  Altered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.

Authors:  Luca Caracciolo; Alessandro Barbon; Sara Palumbo; Cristina Mora; Christopher D Toscano; Francesca Bosetti; Sergio Barlati
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

9.  Regulation of RNA editing by intracellular acidification.

Authors:  Turnee N Malik; Erin E Doherty; Vandana M Gaded; Theodore M Hill; Peter A Beal; Ronald B Emeson
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

10.  Quantitative analysis of focused a-to-I RNA editing sites by ultra-high-throughput sequencing in psychiatric disorders.

Authors:  Hu Zhu; Daniel J Urban; Jared Blashka; Matthew T McPheeters; Wesley K Kroeze; Piotr Mieczkowski; James C Overholser; George J Jurjus; Lesa Dieter; Gouri J Mahajan; Grazyna Rajkowska; Zefeng Wang; Patrick F Sullivan; Craig A Stockmeier; Bryan L Roth
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.